✦ LIBER ✦

313 THE COMBINATION OF LANREOTIDE 90 MG PLUS DEXAMETHASONE IN THE TREATMENT OF HORMONE-REFRACTORY PROSTATE CANCER (HRPCA)

✍ Scribed by I. Mitsogiannis; A. Oeconomou; S. Gravas; L. Mitrakas; V. Tzortzis; G. Moutzouris; M. Melekos

Book ID: 119617645
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 317 KB
Volume: 6
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(07)60312-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

613 Docetaxel (DOC) and mitoxantrone (MI

613 Docetaxel (DOC) and mitoxantrone (MIT) in the management of hormone refractory prostate cancer (HRPCA)

✍ A. Heidenreich; A. Schrader; P. Olbert; C. Ohlmann; A. Hegel; R. Hofmann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 225 KB

306 DOCETAXEL (DOC) AND MITOXANTRON (MIT

306 DOCETAXEL (DOC) AND MITOXANTRON (MIT) IN THE MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER (HRPCA)

✍ C.H. Ohlmann; K. Breitenbach; D. Pfister; U. Engelmann; A. Heidenreich 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Phase I–II study of the somatostatin ana

Phase I–II study of the somatostatin analogue lanreotide in hormone-refractory prostate cancer

✍ C. Maulard, P. Richaud, J. P. Droz, D. Jessueld… 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 402 KB

Satraplatin in the treatment of hormone-

Satraplatin in the treatment of hormone-refractory prostate cancer

✍ Cora N. Sternberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Evaluation of docetaxel plus estramustin

Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer

✍ Akihiro Matsumoto; Atsushi Inoue; Satoshi Yokoi; Kazuyoshi Nozumi; Kanetaka Miya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Oral etoposide in the treatment of hormo

Oral etoposide in the treatment of hormone-refractory prostate cancer

✍ Maha H. Hussain; Kenneth J. Pienta; Bruce G. Redman; Glenn D. Cummings; Lawrence 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views